S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study

BACKGROUND AND OBJECTIVES: S-1-based regimens have been shown to be as effective as other fluoropyrimidine-based regimens with a better safety profile in patients with advanced esophagogastric adenocarcinoma. However, real-world data on S-1 in European patients with advanced esophagogastric adenocar...

Descripción completa

Detalles Bibliográficos
Autor principal: Venerito, Marino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544585/
https://www.ncbi.nlm.nih.gov/pubmed/30825156
http://dx.doi.org/10.1007/s40268-019-0265-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544585/
https://www.ncbi.nlm.nih.gov/pubmed/30825156
http://dx.doi.org/10.1007/s40268-019-0265-0

Ejemplares similares